Abpro specializes in custom monoclonal antibody development. Our proprietary HTP™ platform generates premium antibodies in just 2 months. The HTP™ platform routinely finds success in producing antibodies to GPCR, 1-amino acid specificity, anti-idiotypic, high homology, and other difficult targets. These cell lines serve as reliable, long term antibody sources for many of our partners, who include industry leaders in pharma and biotech, as well as government agencies and academic institutions.
Abpro's other services include custom protein production, assay development, pre-clinical animal services, and a recently launched protein catalog.